nieuws



After Avandia - Does the FDA Have a Drug Problem?

 

After months of deliberation, the agency decided to keep the drug on the market a move worth billions of dollars to GSK but that also may have put millions of patients at risk.

Link


[ Terug naar het hoofdmenu ]